Literature DB >> 22295949

Effects of genetic variation in the P2RX7 gene on pharmacodynamics of a P2X(7) receptor antagonist: a prospective genotyping approach.

Simon M McHugh1, Shilina Roman, Bill Davis, Annelize Koch, Alison M Pickett, Jill C Richardson, Sam R Miller, Sally Wetten, Charles J Cox, Fredrik Karpe, John A Todd, Edward T Bullmore.   

Abstract

AIMS: To investigate the effects of two single nucleotide polymorphisms (SNPs) in the human P2X₇ receptor gene (P2RX7)--1068G>A (A348T) and 1513A>C (E496A)--on P2X₇ receptor function, using a specific receptor antagonist (GSK1370319A) and prospective genetic stratification.
METHODS: Lipopolysaccharide- and ATP-stimulated interleukin-1β production was determined in the presence or absence of GSK1370319A in blood culture from 32 prospectively genotyped subjects.
RESULTS: There was approximately 6.7-fold difference (P < 0.0001) in IC₅₀ for inhibition of ATP-stimulated interleukin-1β release by GSK1370319A between individuals with the homozygous gain--(1068A) and loss-of-function (1513C) genotypes (expressing the 348T, 496E and 348A, 496A alleles, respectively).
CONCLUSIONS: Leukocyte P2X₇ receptors had significantly altered pharmacodynamic responses to a specific antagonist (GSK1370319A), directly related to SNP genotype.
© 2012 GlaxoSmithKline. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22295949      PMCID: PMC3630758          DOI: 10.1111/j.1365-2125.2012.04200.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

Review 1.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

2.  The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.

Authors:  F Rassendren; G N Buell; C Virginio; G Collo; R A North; A Surprenant
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

3.  A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor.

Authors:  B J Gu; W Zhang; R A Worthington; R Sluyter; P Dao-Ung; S Petrou; J A Barden; J S Wiley
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

4.  Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion.

Authors:  Leanne Stokes; Stephen J Fuller; Ronald Sluyter; Kristen K Skarratt; Ben J Gu; James S Wiley
Journal:  FASEB J       Date:  2010-04-01       Impact factor: 5.191

5.  The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.

Authors:  Sushmita Jha; Siddharth Y Srivastava; W June Brickey; Heather Iocca; Arrel Toews; James P Morrison; Vivian S Chen; Denis Gris; Glenn K Matsushima; Jenny P-Y Ting
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

6.  Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.

Authors:  Calliope A Dendrou; Vincent Plagnol; Erik Fung; Jennie H M Yang; Kate Downes; Jason D Cooper; Sarah Nutland; Gillian Coleman; Matthew Himsworth; Matthew Hardy; Oliver Burren; Barry Healy; Neil M Walker; Kerstin Koch; Willem H Ouwehand; John R Bradley; Nicholas J Wareham; John A Todd; Linda S Wicker
Journal:  Nat Genet       Date:  2009-08-23       Impact factor: 38.330

Review 7.  The P2X7 receptor: a key player in IL-1 processing and release.

Authors:  Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

8.  A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium.

Authors:  Nicole Soranzo; Tim D Spector; Massimo Mangino; Brigitte Kühnel; Augusto Rendon; Alexander Teumer; Christina Willenborg; Benjamin Wright; Li Chen; Mingyao Li; Perttu Salo; Benjamin F Voight; Philippa Burns; Roman A Laskowski; Yali Xue; Stephan Menzel; David Altshuler; John R Bradley; Suzannah Bumpstead; Mary-Susan Burnett; Joseph Devaney; Angela Döring; Roberto Elosua; Stephen E Epstein; Wendy Erber; Mario Falchi; Stephen F Garner; Mohammed J R Ghori; Alison H Goodall; Rhian Gwilliam; Hakon H Hakonarson; Alistair S Hall; Naomi Hammond; Christian Hengstenberg; Thomas Illig; Inke R König; Christopher W Knouff; Ruth McPherson; Olle Melander; Vincent Mooser; Matthias Nauck; Markku S Nieminen; Christopher J O'Donnell; Leena Peltonen; Simon C Potter; Holger Prokisch; Daniel J Rader; Catherine M Rice; Robert Roberts; Veikko Salomaa; Jennifer Sambrook; Stefan Schreiber; Heribert Schunkert; Stephen M Schwartz; Jovana Serbanovic-Canic; Juha Sinisalo; David S Siscovick; Klaus Stark; Ida Surakka; Jonathan Stephens; John R Thompson; Uwe Völker; Henry Völzke; Nicholas A Watkins; George A Wells; H-Erich Wichmann; David A Van Heel; Chris Tyler-Smith; Swee Lay Thein; Sekar Kathiresan; Markus Perola; Muredach P Reilly; Alexandre F R Stewart; Jeanette Erdmann; Nilesh J Samani; Christa Meisinger; Andreas Greinacher; Panos Deloukas; Willem H Ouwehand; Christian Gieger
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

9.  Genetics of the P2X7 receptor and human disease.

Authors:  Stephen J Fuller; Leanne Stokes; Kristen K Skarratt; Ben J Gu; James S Wiley
Journal:  Purinergic Signal       Date:  2009-03-25       Impact factor: 3.765

Review 10.  Structural interpretation of P2X receptor mutagenesis studies on drug action.

Authors:  Richard J Evans
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

View more
  9 in total

1.  Ligand-independent activation of the P2X7 receptor by Hsp90 inhibition stimulates motor neuron apoptosis.

Authors:  Amy L Strayer; Cassandra N Dennys-Rivers; Karina C Ricart; Narae Bae; Joseph S Beckman; Maria Clara Franco; Alvaro G Estevez
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

Review 2.  Extracellular Nucleotides and P2 Receptors in Renal Function.

Authors:  Volker Vallon; Robert Unwin; Edward W Inscho; Jens Leipziger; Bellamkonda K Kishore
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

Review 3.  The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy.

Authors:  B M Williams; C L Cliff; K Lee; P E Squires; C E Hills
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

Review 4.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

Review 5.  P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer - A Mini Review.

Authors:  Yonglin Mai; Zhihua Guo; Weiqiang Yin; Nanshan Zhong; Peter V Dicpinigaitis; Ruchong Chen
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

6.  What is the point of large-scale collections of human induced pluripotent stem cells?

Authors:  Ruth McKernan; Fiona M Watt
Journal:  Nat Biotechnol       Date:  2013-10       Impact factor: 54.908

7.  Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.

Authors:  Daniel Ursu; Philip Ebert; Emily Langron; Cara Ruble; Leanne Munsie; Wei Zou; Bonnie Fijal; Yue-Wei Qian; Terry A McNearney; Adrian Mogg; Olivera Grubisha; Kalpana Merchant; Emanuele Sher
Journal:  Mol Pain       Date:  2014-06-16       Impact factor: 3.395

Review 8.  P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?

Authors:  Daniel Aeschlimann; Vera Knäuper
Journal:  Amino Acids       Date:  2016-08-25       Impact factor: 3.520

Review 9.  Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes.

Authors:  Chelsy L Cliff; Bethany M Williams; Christos E Chadjichristos; Ulrik Mouritzen; Paul E Squires; Claire E Hills
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.